Followers | 28 |
Posts | 1889 |
Boards Moderated | 0 |
Alias Born | 04/04/2017 |
Monday, September 19, 2022 3:15:30 PM
Nothing abnormal about SFIO trading that many/most other OTC hasn't been seeing I'll post this comparison again...everybody in same 20-21 bagholder issue...OTC stocks have to much " left behind" stigma to recover soon.
Heres the point Ive been trying to make; AABB showing Annual sales of about 2.77M, at a MC of $150M that gives it a PS of 54(higher is NOT better) Net neg profit
HMBL Sales ~4M, MC 71M, PS 18 still net neg profit
DPLS Sales ~11M, MC 156M PS 11 net neg profit getting better
ILUS Sales ~ 30M (last quarter was huge spike, probably not ongoing) MC 130M, Now, PS down from recently around 10 to 4.5. Barely profitable
Look at our SFIO: Sales ~ 25M (will assume till audit), MC 23M, PS......0.92!!!! and let not forget profitable!!! Positive Book value.
Even if they are fudging the numbers by 50%, they are outperforming these...and 99% of the OTC stocks.
Are they perfect...No!! But I do think some of this new management will sort things out. As Ive asked, until OTC becomes credible again....what better bet you got?!!!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM